Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

GLA/DRST real-world outcome analysis of CAR T-cell therapies for large B-cell lymphoma in Germany

Blood (2022) 140 (4): 349–358.

https://doi.org/10.1182/blood.2021015209

Published: 2022

Includes: Supplemental data

Journal Articles

Standard of Care CAR-T Cell Therapy for Large B-Cell Lymphoma (LBCL): Does Bridging Efficacy Matter? a German GLA/DRST Real World Analysis

Blood (2021) 138 (Supplement 1): 3822.

https://doi.org/10.1182/blood-2021-146120

Published: 2021

Journal Articles

NIH-Defined Graft-Versus-Host Disease in Patients with Acute Lymphoblastic Leukemia: Natural History, Prognostic Impact and Effect of Donor Lymphocyte Infusions

Theis H. Terwey, Tanja M. Le Duc, Philipp G. Hemmati, Lam G. Vuong, Peter Martus, Philipp D. le Coutre, MD, Bernd Dörken, Renate Arnold

Blood (2011) 118 (21): 4547.

https://doi.org/10.1182/blood.V118.21.4547.4547

Published: 2011

Journal Articles

Natural History, Risk Factors and Prognostic Impact of Graft-Versus-Host Disease Classified According to the National Institute of Health Criteria in Patients Receiving Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia

Theis H Terwey, Arturo Vega-Ruiz, Philipp G. Hemmati, Peter Martus, Ekkehart Dietz, Lam G Vuong, Philipp D le Coutre, Bernd Dörken, Renate Arnold

Blood (2010) 116 (21): 899.

https://doi.org/10.1182/blood.V116.21.899.899

Published: 2010

Journal Articles

Incidence and Clinical Characteristics of Chronic Graft Versus Host Disease (cGVHD) According to the National Institutes of Health (NIH) Criteria in Patients Transplanted for Acute Myeloid Leukemia (AML).

Arturo Vega, Peter Martus, Theis Terwey, Christian Jakob, MD, Lam G Vuong, Philipp Hemmati, Philipp D. le Coutre, MD, Renate Arnold, MD

Blood (2009) 114 (22): 4639.

https://doi.org/10.1182/blood.V114.22.4639.4639

Published: 2009

Journal Articles

Meningeal Dissemination (MD) in Primary CNS Lymphoma (PCNSL): Multimodal Diagnosis, Presentation and Outcome in a Large Monocenter Patient Cohort

Philipp Kiewe, Agnieszka Korfel, Lars Fischer, Peter Martus, Eckhard Thiel

Blood (2008) 112 (11): 5300.

https://doi.org/10.1182/blood.V112.11.5300.5300

Published: 2008

Journal Articles

Mutations in Specific NOTCH1 Domains Convey a Distinct Phenotype in Adult Acute T-Lymphoblastic Leukemia.

Julia Thibaut, MS, Nicola Goekbuget, MD, Peter Martus, PhD, Thomas Burmeister, MD PhD, Stefan Schwartz, MD, Dieter Hoelzer, MD, Eckhard Thiel, MD, Wolf K. Hofmann, MD, Claudia D. Baldus, MD

Blood (2007) 110 (11): 152.

https://doi.org/10.1182/blood.V110.11.152.152

Published: 2007

Journal Articles

Low Dose Liposomal Amphotericin B (L-AmB) as Prophylaxis of Invasive Fungal Infections (IFI) in Neutropenic Patients (pts): Is It Cost Effective?.

Olaf Penack, MD, Peter Martus, PhD, Eckhard Thiel, MD, Igor W. Blau, MD

Blood (2006) 108 (11): 3324.

https://doi.org/10.1182/blood.V108.11.3324.3324

Published: 2006

Journal Articles

The Identification of ERG Related Pathways Pinpoints to Mechanisms Implicated in the Inferior Outcome of Acute T-Lymphoblastic Leukemia (T-ALL) with High ERG Expression.

Claudia D. Baldus, MD, Michael D. Radmacher, PhD, Clara D. Bloomfield, MD, Peter Martus, PhD, Stefan Schwartz, MD, Nicola Goekbuget, MD, Dieter Hoelzer, MD, Eckhard Thiel, MD, Wolf K. Hofmann, MD

Blood (2006) 108 (11): 1828.

https://doi.org/10.1182/blood.V108.11.1828.1828

Published: 2006

Journal Articles

Toxicity and Risk Factors Contributing to Delayed Methotrexate (MTX) Elimination in Adult/Elderly Patients (pts) Treated with High-Dose Methotrexate Therapy (HDMTX), a 2-Year, Single Center Survey.

Stefan Schwartz, MD, Peter Martus, PhD, Wolf-Dieter Ludwig, MD, Renate Arnold, MD, Markus Ruhnke, MD, Agnieszka Korfel, MD, David Kopitzke, Tim Auton, PhD, Eckhard Thiel, MD

Blood (2006) 108 (11): 2439.

https://doi.org/10.1182/blood.V108.11.2439.2439

Published: 2006

Journal Articles

International Primary Central Nervous System Lymphoma Collaborative Group (IPCG) Study on Low-Grade Primary Central Nervous System Lymphoma in Immunocompetent Patients.

Agnieszka Korfel, MD, Kristoph Jahnke, MD, Brian P. O’Neill, MD, Jean-Yves Blay, MD, Lauren Abrey, MD, Peter Martus, Philip M.P. Poortmans, MD, Tamara N. Shenkier, MD, Tracy T. Batchelor, MD, Edward A. Neuwelt, MD, Jeffrey J. Raizer, MD, Hendrik Pels, MD, Ulrich Herrlinger, MD, Eckhard Thiel, MD

Blood (2005) 106 (11): 3343.

https://doi.org/10.1182/blood.V106.11.3343.3343

Published: 2005

Journal Articles

A Randomized Phase III Trial of Low Dose Liposomal Amphotericin B (L-AmB) as Prophylaxis of Invasive Fungal Infections (IFI) in Neutropenic Patients (pts).

Olaf Penack, MD, Stefan Schwartz, MD, Peter Martus, MD, Mark Reinwald, MD, Martin Schmidt-Hieber, MD, Eckhard Thiel, MD, Igor W. Blau, MD

Blood (2005) 106 (11): 82.

https://doi.org/10.1182/blood.V106.11.82.82

Published: 2005

NARROW

GLA/DRST real-world outcome analysis of CAR T-cell therapies for large B-cell lymphoma in Germany

Standard of Care CAR-T Cell Therapy for Large B-Cell Lymphoma (LBCL): Does Bridging Efficacy Matter? a German GLA/DRST Real World Analysis

NIH-Defined Graft-Versus-Host Disease in Patients with Acute Lymphoblastic Leukemia: Natural History, Prognostic Impact and Effect of Donor Lymphocyte Infusions

Natural History, Risk Factors and Prognostic Impact of Graft-Versus-Host Disease Classified According to the National Institute of Health Criteria in Patients Receiving Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia

Incidence and Clinical Characteristics of Chronic Graft Versus Host Disease (cGVHD) According to the National Institutes of Health (NIH) Criteria in Patients Transplanted for Acute Myeloid Leukemia (AML).

Meningeal Dissemination (MD) in Primary CNS Lymphoma (PCNSL): Multimodal Diagnosis, Presentation and Outcome in a Large Monocenter Patient Cohort

Mutations in Specific NOTCH1 Domains Convey a Distinct Phenotype in Adult Acute T-Lymphoblastic Leukemia.

Low Dose Liposomal Amphotericin B (L-AmB) as Prophylaxis of Invasive Fungal Infections (IFI) in Neutropenic Patients (pts): Is It Cost Effective?.

The Identification of ERG Related Pathways Pinpoints to Mechanisms Implicated in the Inferior Outcome of Acute T-Lymphoblastic Leukemia (T-ALL) with High ERG Expression.

Toxicity and Risk Factors Contributing to Delayed Methotrexate (MTX) Elimination in Adult/Elderly Patients (pts) Treated with High-Dose Methotrexate Therapy (HDMTX), a 2-Year, Single Center Survey.

International Primary Central Nervous System Lymphoma Collaborative Group (IPCG) Study on Low-Grade Primary Central Nervous System Lymphoma in Immunocompetent Patients.

A Randomized Phase III Trial of Low Dose Liposomal Amphotericin B (L-AmB) as Prophylaxis of Invasive Fungal Infections (IFI) in Neutropenic Patients (pts).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only